Literature DB >> 18015959

Correlation of in vitro Sulfonamide Resistance of the Gonococcus with Results of Sulfonamide Therapy.

C M Carpenter, H Ackerman, M E Winchester, J Whittle.   

Abstract

Entities:  

Year:  1944        PMID： 18015959      PMCID： PMC1626185          DOI： 10.2105/ajph.34.3.250

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  7 in total

1.  Treatment problems of gonorrhoea.

Authors:  R R WILLCOX
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

2.  Studies on Penicillinase: III. The Effect of Antipenicillinase on Penicillin-resistant Organisms.

Authors:  R D Housewright; R J Henry
Journal:  J Bacteriol       Date:  1947-02       Impact factor: 3.490

3.  Sulfamethazine: In Vitro Action on Enteric Pathogens as Compared with Sulfadiazine and Sulfamerazine.

Authors:  F B Schweinburg; I J Yetwin
Journal:  J Bacteriol       Date:  1945-02       Impact factor: 3.490

Review 4.  A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia.

Authors:  R R Willcox
Journal:  Br J Vener Dis       Date:  1970-06

5.  The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Authors:  Robert D Kirkcaldy; Hillard S Weinstock; Page C Moore; Susan S Philip; Harold C Wiesenfeld; John R Papp; Peter R Kerndt; Shacondra Johnson; Khalil G Ghanem; Edward W Hook
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

6.  Neisseria gonorrhoeae isolated from disseminated and localised infections in pre-penicillin era. Auxotypes and antibacterial drug resistances.

Authors:  B W Catlin; A Reyn
Journal:  Br J Vener Dis       Date:  1982-06

7.  Effectiveness of Bazhengsan formula as an adjunctive therapy to ceftriaxone for female patients with uncomplicated gonorrhea: A pilot study.

Authors:  Ning Li; Li Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.